P-75 Reirradiation in head and neck recurrent cancer or second primary. Our experience

Oral Oncology ◽  
2021 ◽  
Vol 118 ◽  
pp. 1-2
Author(s):  
Lucia Gutierrez Bayard ◽  
Raquel Rodriguez Sanchez ◽  
Cristina Muñoz Higueras
Keyword(s):  
Head And Neck ◽  
Second Primary ◽  
Recurrent Cancer ◽  
P 75

Mutation analysis of second primary tumors in head and neck cancer in Taiwanese patients through next-generation sequencing

2021 ◽  
Author(s):  
Ting-Yuan Liu ◽  
Chien-Chin Lee ◽  
Yu-Chia Chen ◽  
Ya-Sian Chang ◽  
Hsi-Yuan Huang ◽  
...  
Keyword(s):  
Head And Neck Cancer ◽  
Head And Neck ◽  
Clinical Diagnosis ◽  
Neck Cancer ◽  
Driver Gene ◽  
Second Primary ◽  
Primary Cancer ◽  
Primary Tumors ◽  
Recurrent Cancer ◽  
Second Primary Tumors

Abstract Head and neck cancer has poor overall survival. Patients with head and neck cancer more frequently develop second primary tumors than do patients with other cancers, leading to a poor prognosis. In this study, we used next-generation sequencing to analyze and compare mutations between first tumors and second tumors in head and neck cancer. We retrieved tumor tissues collected from 15 patients who were diagnosed twice as having cancer. We used driver gene and trunk mutations to distinguish between recurrent cancer and primary cancer in oral cancer. We observed unique driver gene mutations in three patients with an initial clinical diagnosis of recurrent cancer; hence, we believe that the corresponding patients had primary cancer. Four patients with an initial clinical diagnosis of primary cancer were found to actually have recurrent cancer according to our results. Three (75%) patients with recurrent cancer demonstrated NUP98 mutations. NUP98 mutations may be a new biomarker for diagnosing recurrent oral cancer. Genetic testing can be used to enhance the accuracy of clinical diagnosis.

Hubungan ekspresi p53, Bcl-2, c-Myc dan MMP-9 dengan gambaran klinikopatologi karsinoma sel skuamosa kepala-leher

2016 ◽  
Vol 46 (1) ◽  
pp. 53
Author(s):  
Azwar Azwar ◽  
Sofia Mubarika ◽  
Agus Surono
Keyword(s):  
Squamous Cell Carcinoma ◽  
Cell Carcinoma ◽  
Head And Neck ◽  
Squamous Cell ◽  
Tumor Location ◽  
Neck Squamous Cell Carcinoma ◽  
Second Primary ◽  
Cross Sectional ◽  
P53 Expression ◽  
Local Metastasis

Latar belakang: Karsinoma sel skuamosa kepala dan leher merupakan salah satu kanker terseringdi seluruh dunia. Pendekatan pengobatan agresif dan multidisiplin telah dilakukan, namun belum adapeningkatan yang signifikan dalam kelangsungan hidup 5 tahun, selama 20 tahun terakhir. Kegagalanpengobatan terjadi dalam bentuk kekambuhan lokoregional, metastasis jauh, dan/atau tumor primer kedua.Berbagai penanda molekular tumor telah diteliti untuk mengetahui potensinya dalam memprediksi hasilpenyakit atau respon terhadap terapi.Tujuan: Mengetahui hubungan ekspresi protein p53, Bcl-2, c-Myc,dan MMP-9 berdasarkan gambaran klinikopatologis karsinoma sel skuamosa kepala dan leher di RumahSakit dr. Zainoel Abidin.Metode: Studi menggunakan desain cross sectional. Sampel terdiri dari 60blok parafin karsinoma sel skuamosa kepala dan leher. Prosedur pewarnaan imunohistokimia dilakukandengan menggunakan antibodi monoklonal terhadap p53, Bcl-2, c-Myc, dan MMP-9. Ekspresi proteinp53, Bcl-2, c-Myc, dan MMP-9 dianalisis secara imunohistokimia pada karsinoma sel skuamosa kepaladan leher kemudian hasilnya dihubungkan dengan parameter klinikopatologis seperti usia, jenis kelamin,lokasi tumor, diferensiasi tumor, metastasis kelenjar getah bening dan stadium tumor, kemudian dianalisisstatistik dengan Chi square.Hasil: Hasil penelitian menunjukkan terdapat hubungan bermakna tingkatekspresi p53 dengan metastasis lokal (p=0,021) dan ada hubungan bermakna tingkat ekspresi MMP-9dengan lokasi tumor (p=0,026). Tidak terdapat hubungan ekspresi p53, Bcl-2, cMyc, dan MMP-9 terhadapusia, jenis kelamin, stadium tumor, diferensiasi histologi, tingkat T, N, dan metastasis jauh.Kesimpulan:Ada hubungan ekpresi p53 dengan metastasis kelenjar limfe regional dan ekspresi MMP-9 dengan lokasitumor pada karsinoma sel skuamosa kepala dan leher. Kata kunci: Karsinoma sel skuamosa kepala dan leher, p53, Bcl-2, c-Myc, MMP-9 ABSTRACTBackground: Head and neck squamous cell carcinoma (HNSCC) is one of the most commoncancers world wide. Although aggressive and multidisciplinary approach to the treatment has been done,there is no significant improvement in 5-year survival in the last 20 years. Treatment failure occurredin the form of locoregional recurrence, distant metastasis, and/or a second primary tumor. A variety oftumor molecular markers have been studied to determine their potential in predicting disease outcome orresponse to the therapy. Purpose: To investigate correlation p53, Bcl-2, c-Myc, and MMP-9 expressionto clinicopathologic parameter in head and neck squamous cell carcinoma patient in dr. Zainoel Abidinhospital. Methods: Cross sectional design study. The sample was consisted of 60 paraffin blocks ofhead and neck squamous cell carcinoma. Procedure of immunohistochemical staining used monoclonalantibodies against p53, Bcl-2, c-Myc, and MMP-9. Expression of p53 protein, Bcl-2, c-Myc, and MMP-9were analyzed by immunohistochemistry in head and neck squamous cell carcinoma. Then, the results were linked to clinicopathologic parameters such as age, sex, tumor location, tumor differentiation,lymph node metastasis and tumor stage, and statistically analyzed with Chi square. Results: The resultsshowed there were significant correlation between p53 expression level with local metastasis (p=0,021)and significant correlation of MMP-9 expression levels with tumor location (p=0,026). There were norelationship of p53, Bcl-2, cMyc and MMP-9 expressions based on age, sex, stage tumor, histologicdifferentiation, level of T, N, and distant metastases. Conclusion: There were relationships between p53expression with local metastasis and MMP-9 expression with tumor location in head and neck squamouscell carcinoma. Keywords: Head and neck squamous cell carcinoma, p53, Bcl-2, c-Myc, MMP-9

scholarly journals Early detection of esophageal second primary tumors using Lugol chromoendoscopy in patients with head and neck cancer: A systematic review and meta‐analysis

Head & Neck ◽  
2018 ◽  
Vol 41 (4) ◽  
pp. 1122-1130 ◽  
Author(s):  
Oisín Bugter ◽  
Steffi E. M. van de Ven ◽  
Jose A. Hardillo ◽  
Marco J. Bruno ◽  
Arjun D. Koch ◽  
...  
Keyword(s):  
Systematic Review ◽  
Head And Neck Cancer ◽  
Early Detection ◽  
Head And Neck ◽  
Neck Cancer ◽  
Meta Analysis ◽  
Second Primary ◽  
Primary Tumors ◽  
Second Primary Tumors

Reirradiation of Recurrent and Second Primary Head and Neck Cancer With Proton Therapy

2016 ◽  
Vol 96 (4) ◽  
pp. 808-819 ◽  
Author(s):  
Mark W. McDonald ◽  
Omid Zolali-Meybodi ◽  
Stephen J. Lehnert ◽  
Neil C. Estabrook ◽  
Yuan Liu ◽  
...  
Keyword(s):  
Head And Neck Cancer ◽  
Head And Neck ◽  
Neck Cancer ◽  
Proton Therapy ◽  
Second Primary

Impact of second primary esophageal or lung cancer on survival of patients with head and neck cancer

Oral Oncology ◽  
2010 ◽  
Vol 46 (4) ◽  
pp. 249-254 ◽  
Author(s):  
Min-Chi Chen ◽  
Wei-Chao Huang ◽  
Chunghuang Hubert Chan ◽  
Ping-Tsung Chen ◽  
Kuan-Der Lee
Keyword(s):  
Lung Cancer ◽  
Head And Neck Cancer ◽  
Head And Neck ◽  
Neck Cancer ◽  
Second Primary

Clinical Analysis of Second Primary Esophageal Cancer after Treatment for Head and Neck Cancer

2021 ◽  
Vol 72 (4) ◽  
pp. 196-203
Author(s):  
Kohei Saisho ◽  
Satoru Matono ◽  
Naoki Mori ◽  
Haruhiro Hino ◽  
Masahiro Fujisaki ◽  
...  
Keyword(s):  
Esophageal Cancer ◽  
Head And Neck Cancer ◽  
Head And Neck ◽  
Neck Cancer ◽  
Clinical Analysis ◽  
Second Primary
Sign in / Sign up

Export Citation Format

Share Document